One explanation for this is our inability to differentiate between symptoms attributable to detrusor overactivity (DO) and those caused by bladder ... treatment comprises men with urodynamic ...

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB ... receiving pharmacologic treatment for BPH.

Overactive bladder (OAB) in men is an entity that may be challenging to diagnose and treat, especially in the presence of bladder outlet obstruction. The application of oral medical treatments of ...

Urination problems affect millions of men worldwide, often developing so gradually that many dismiss early warning signs.

Your health care providers can help you discover the treatments best for you. Overactive bladder can be triggered, or irritated, by many things, from medications to a simple cola. It's a great ...

Mostly, older women are more prone to an overactive bladder usually, but a recent representative cohort study indicates the number of men with overactive bladder is significantly on the rise.

This phenotypic approach could avoid unnecessary or ineffective treatment ... is a major risk factor for falls. Overactive Bladder in Men with Newly Diagnosed Localized Prostate Cancer Overactive ...

An overactive bladder may be temporary or become a chronic condition. How long the symptoms last may depend on factors like the underlying cause and treatment adherence. Some conditions may cause ...

Somewhere between 15 and 20 million people are affected by overactive bladder and/or incontinence ... as women get a little bit older. But men are also affected by it too. where their prostate ...